"Organ Sparing Treatments" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Techniques, procedures, and therapies carried out on diseased organs in such a way to avoid complete removal of the organ and preserve the remaining organ function.
Descriptor ID |
D059351
|
MeSH Number(s) |
E02.674
|
Concept/Terms |
Organ Sparing Treatments- Organ Sparing Treatments
- Organ Sparing Treatment
- Sparing Treatment, Organ
- Sparing Treatments, Organ
- Treatment, Organ Sparing
- Treatments, Organ Sparing
|
Below are MeSH descriptors whose meaning is more general than "Organ Sparing Treatments".
Below are MeSH descriptors whose meaning is more specific than "Organ Sparing Treatments".
This graph shows the total number of publications written about "Organ Sparing Treatments" by people in this website by year, and whether "Organ Sparing Treatments" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
2019 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Organ Sparing Treatments" by people in Profiles.
-
The modern approach to the nipple-sparing mastectomy. J Surg Oncol. 2020 Jul; 122(1):29-35.
-
The "Nipple Whipple"?! A Pilot Study to Assess the Ergonomic Effects of Nipple-Sparing Mastectomy. Ann Surg Oncol. 2019 Oct; 26(10):3216-3223.
-
Laparoscopic Parenchymal-Sparing Hepatectomy: the New Maximally Minimal Invasive Surgery of the Liver-a Systematic Review and Meta-Analysis. J Gastrointest Surg. 2019 04; 23(4):860-869.
-
Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity. Am J Clin Oncol. 2019 01; 42(1):1-5.
-
A model for predicting the dose to the parotid glands based on their relative overlapping with planning target volumes during helical radiotherapy. J Appl Clin Med Phys. 2018 Mar; 19(2):48-53.
-
Integral dose delivered to normal brain with conventional intensity-modulated radiotherapy (IMRT) and helical tomotherapy IMRT during partial brain radiotherapy for high-grade gliomas with and without selective sparing of the hippocampus, limbic circuit and neural stem cell compartment. J Med Imaging Radiat Oncol. 2013 Jun; 57(3):378-83.
-
Chemoradiation for patients with large-volume laryngeal cancers. Head Neck. 2012 Aug; 34(8):1162-7.